Insider · CIK 0002142007
Tim Lohoff
Files at BRVE (Braveheart Bio, Inc.). First filing -, latest -.
In brief
Tim Lohoff files SEC Form 4 as director at BRVE (Braveheart Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tim Lohoff has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | BRVE Braveheart Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Aug 7, 2026 |
Questions about Tim Lohoff
Answered from the filings on this page, as of the latest one.
Is Tim Lohoff buying or selling?
Tim Lohoff has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tim Lohoff's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tim Lohoff has 0.
Where does Tim Lohoff file Form 4?
Tim Lohoff has filed Form 4 at BRVE (Braveheart Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.